IRIS
RIVARA, Mirko
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.434
AS - Asia 2.285
EU - Europa 1.931
SA - Sud America 251
AF - Africa 134
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.349
SG - Singapore 753
CN - Cina 698
IT - Italia 443
VN - Vietnam 347
FI - Finlandia 297
SE - Svezia 245
IE - Irlanda 232
DE - Germania 196
BR - Brasile 191
HK - Hong Kong 186
UA - Ucraina 142
NL - Olanda 84
BD - Bangladesh 78
GB - Regno Unito 76
ZA - Sudafrica 73
FR - Francia 71
RU - Federazione Russa 62
CA - Canada 55
TR - Turchia 42
IN - India 36
CI - Costa d'Avorio 25
KR - Corea 22
JP - Giappone 19
PH - Filippine 19
AR - Argentina 18
MX - Messico 17
CZ - Repubblica Ceca 16
IQ - Iraq 16
BE - Belgio 15
PL - Polonia 12
EC - Ecuador 11
TH - Thailandia 11
PK - Pakistan 10
CO - Colombia 9
EG - Egitto 8
ES - Italia 8
ID - Indonesia 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
TN - Tunisia 7
VE - Venezuela 7
AT - Austria 6
JO - Giordania 6
PT - Portogallo 6
CR - Costa Rica 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
ET - Etiopia 3
IR - Iran 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
AM - Armenia 2
BB - Barbados 2
KE - Kenya 2
KW - Kuwait 2
LY - Libia 2
NI - Nicaragua 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 7.037
Salva come PNG Salva come JPEG
Città #
Singapore 393
Ashburn 295
Dublin 232
Chandler 226
San Jose 218
Hong Kong 175
Beijing 171
Jacksonville 154
Santa Clara 145
Dallas 115
Ann Arbor 97
Ho Chi Minh City 97
Boardman 93
Parma 93
Hanoi 86
Johannesburg 71
Munich 71
Hefei 69
New York 69
Dearborn 67
Nanjing 62
Los Angeles 58
Milan 52
Shanghai 51
Lauterbourg 45
Princeton 45
Chicago 34
Helsinki 34
Wilmington 32
Izmir 31
San Mateo 29
Toronto 29
Moscow 26
Abidjan 25
Frankfurt am Main 25
Turku 24
Buffalo 23
Council Bluffs 21
London 20
Seoul 19
Shenyang 18
Guangzhou 17
Nanchang 17
Seattle 17
Tokyo 17
Columbus 16
Da Nang 16
Haiphong 16
Jinan 16
Kunming 16
São Paulo 15
Bremen 14
Brussels 14
Des Moines 14
Hebei 14
The Dalles 13
Jiaxing 11
Modena 11
Bologna 10
Brno 10
Brooklyn 10
Chennai 10
Reggio Emilia 10
Woodbridge 10
Warsaw 9
Amsterdam 8
Changsha 8
Montreal 8
Nuremberg 8
Tianjin 8
Baghdad 7
Bengaluru 7
Rome 7
Ankara 6
Atlanta 6
Belo Horizonte 6
Chengdu 6
Genoa 6
Houston 6
Jakarta 6
Mexico City 6
Ottawa 6
Piacenza 6
Stockholm 6
Vienna 6
Amman 5
Auburn Hills 5
Falls Church 5
Hangzhou 5
Manchester 5
Norwalk 5
Quito 5
Redondo Beach 5
Thái Bình 5
Tunis 5
Abbiategrasso 4
Ancona 4
Brescia 4
Bắc Ninh 4
Calgary 4
Totale 4.166
Salva come PNG Salva come JPEG
Nome #
Chemico-Physical Properties of Some 1,1′-Bis-alkyl-2,2′-hexane-1,6-diyl-bispyridinium Chlorides Hydrogenated and Partially Fluorinated for Gene Delivery 222
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 203
Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated Gemini bispyridinium Surfactants with Six Methylene Spacers 201
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 198
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 198
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 196
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 183
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 178
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 177
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 162
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 159
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 157
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 155
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 155
Antioxidant and cytoprotective activity of indole derivatives related to melatonin 153
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 153
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 151
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 150
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 150
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 149
Advances in Design and Development of Sodium Channel Blockers. 149
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 147
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 142
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 142
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 142
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 141
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 141
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 139
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 138
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 137
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 132
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 129
Drug repurposing approaches to fight Dengue virus infection and related diseases 127
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 120
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 119
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 115
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 114
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 113
NMR Analysis of a Series of Imidazobenzoxazines 112
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 111
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 108
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 108
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 104
Sodium channel blockers for neuropathic pain. 104
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 103
Sodium channel blockers: a patent review (2010 - 2014) 101
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 98
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 96
NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet syndrome 88
Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release 71
Recent advances in the discovery of ALKBH 1–8 inhibitors. 67
Totale 7.108
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.085
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022229 3 2 5 18 14 7 29 26 21 17 17 70
2022/2023929 106 108 68 57 71 118 17 44 275 12 36 17
2023/2024411 22 32 11 14 43 84 38 29 19 21 35 63
2024/20251.277 64 78 99 90 72 137 41 77 101 114 128 276
2025/20262.905 251 291 359 305 396 171 305 90 328 216 104 89
Totale 7.108